Annual Debt To Equity
-1.19
+0.05+4.03%
31 December 2023
Summary:
Galectin Therapeutics annual debt to equity ratio is currently -1.19, with the most recent change of +0.05 (+4.03%) on 31 December 2023. During the last 3 years, it has fallen by -1.19 (-100.00%). GALT annual debt to equity is now -110.71% below its all-time high of 11.11, reached on 31 December 2021.GALT Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-1.13
+0.01+0.88%
30 September 2024
Summary:
Galectin Therapeutics quarterly debt to equity ratio is currently -1.13, with the most recent change of +0.01 (+0.88%) on 30 September 2024. Over the past year, it has increased by +0.07 (+5.83%). GALT quarterly debt to equity is now -100.23% below its all-time high of 501.80, reached on 30 September 2006.GALT Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | +5.8% |
| 3 y3 years | -100.0% | -154.1% |
| 5 y5 years | -100.0% | -100.0% |
GALT Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -110.7% | +4.0% | -110.2% | +76.1% |
| 5 y | 5 years | -110.7% | +4.0% | -110.2% | +76.1% |
| alltime | all time | -110.7% | +4.0% | -100.2% | +79.9% |
Galectin Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -1.13(-0.9%) |
| June 2024 | - | -1.14(-1.7%) |
| Mar 2024 | - | -1.16(-2.5%) |
| Dec 2023 | -1.19(-4.0%) | -1.19(-0.8%) |
| Sept 2023 | - | -1.20(+1.7%) |
| June 2023 | - | -1.18(+0.9%) |
| Mar 2023 | - | -1.17(-5.6%) |
| Dec 2022 | -1.24(-111.2%) | -1.24(-7.5%) |
| Sept 2022 | - | -1.34(-31.3%) |
| June 2022 | - | -1.95(-58.8%) |
| Mar 2022 | - | -4.73(-142.6%) |
| Dec 2021 | 11.11(>+9900.0%) | 11.11(+431.6%) |
| Sept 2021 | - | 2.09(+266.7%) |
| June 2021 | - | 0.57(>+9900.0%) |
| Mar 2021 | - | 0.00(0.0%) |
| Dec 2020 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2020 | - | 0.00(0.0%) |
| June 2020 | - | 0.00(0.0%) |
| Mar 2020 | - | 0.00(0.0%) |
| Dec 2019 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2019 | - | 0.00(0.0%) |
| June 2019 | - | 0.00(0.0%) |
| Mar 2019 | - | 0.00(0.0%) |
| Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2018 | - | 0.00(0.0%) |
| June 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2017 | - | 0.00(0.0%) |
| June 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2016 | - | 0.00(0.0%) |
| June 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2015 | - | 0.00(0.0%) |
| June 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2014 | - | 0.00(0.0%) |
| June 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2013 | - | 0.00(0.0%) |
| June 2013 | - | 0.00(0.0%) |
| Mar 2013 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2012 | - | 0.00(0.0%) |
| June 2012 | - | 0.00(0.0%) |
| Mar 2012 | - | 0.00(0.0%) |
| Dec 2011 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2011 | - | 0.00(0.0%) |
| June 2011 | - | 0.00(0.0%) |
| Mar 2011 | - | 0.00(0.0%) |
| Dec 2010 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2010 | - | 0.00(0.0%) |
| June 2010 | - | 0.00(0.0%) |
| Mar 2010 | - | 0.00(0.0%) |
| Dec 2009 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2009 | - | 0.00(0.0%) |
| June 2009 | - | 0.00(0.0%) |
| Mar 2009 | - | 0.00(-100.0%) |
| Dec 2008 | -0.43(<-9900.0%) | -0.43(<-9900.0%) |
| Sept 2008 | - | 0.00(0.0%) |
| June 2008 | - | 0.00(0.0%) |
| Mar 2008 | - | 0.00(0.0%) |
| Dec 2007 | 0.00(0.0%) | 0.00(-100.0%) |
| Sept 2007 | - | -0.16(-125.0%) |
| June 2007 | - | 0.64(>+9900.0%) |
| Mar 2007 | - | 0.00(0.0%) |
| Dec 2006 | 0.00(0.0%) | 0.00(-100.0%) |
| Sept 2006 | - | 501.80(-9013.0%) |
| June 2006 | - | -5.63(+36.7%) |
| Mar 2006 | - | -4.12(<-9900.0%) |
| Dec 2005 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2005 | - | 0.00(0.0%) |
| June 2005 | - | 0.00(0.0%) |
| Mar 2005 | - | 0.00(0.0%) |
| Dec 2004 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2004 | - | 0.00(0.0%) |
| June 2004 | - | 0.00(0.0%) |
| Mar 2004 | - | 0.00(0.0%) |
| Dec 2003 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2003 | - | 0.00(0.0%) |
| June 2003 | - | 0.00(-100.0%) |
| Mar 2003 | - | 0.01(0.0%) |
| Dec 2002 | 0.01(-93.8%) | 0.01(-90.0%) |
| Sept 2002 | - | 0.10(-70.6%) |
| June 2002 | - | 0.34(-10.5%) |
| Mar 2002 | - | 0.38(+137.5%) |
| Dec 2001 | 0.16 | 0.16(-60.0%) |
| Sept 2001 | - | 0.40(-121.1%) |
| June 2001 | - | -1.90 |
FAQ
- What is Galectin Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Galectin Therapeutics?
- What is Galectin Therapeutics annual debt to equity year-on-year change?
- What is Galectin Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly debt to equity year-on-year change?
What is Galectin Therapeutics annual debt to equity ratio?
The current annual debt to equity of GALT is -1.19
What is the all time high annual debt to equity for Galectin Therapeutics?
Galectin Therapeutics all-time high annual debt to equity ratio is 11.11
What is Galectin Therapeutics annual debt to equity year-on-year change?
Over the past year, GALT annual debt to equity ratio has changed by +0.05 (+4.03%)
What is Galectin Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of GALT is -1.13
What is the all time high quarterly debt to equity for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly debt to equity ratio is 501.80
What is Galectin Therapeutics quarterly debt to equity year-on-year change?
Over the past year, GALT quarterly debt to equity ratio has changed by +0.07 (+5.83%)